214 related articles for article (PubMed ID: 33274768)
1. Revisiting prostate cancer metabolism: From metabolites to disease and therapy.
Cardoso HJ; Carvalho TMA; Fonseca LRS; Figueira MI; Vaz CV; Socorro S
Med Res Rev; 2021 May; 41(3):1499-1538. PubMed ID: 33274768
[TBL] [Abstract][Full Text] [Related]
2. The role of glutamine metabolism in castration-resistant prostate cancer.
Zhao B; Wang J; Chen L; Wang H; Liang CZ; Huang J; Xu LF
Asian J Androl; 2023; 25(2):192-197. PubMed ID: 36629158
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. The fat side of prostate cancer.
Zadra G; Photopoulos C; Loda M
Biochim Biophys Acta; 2013 Oct; 1831(10):1518-32. PubMed ID: 23562839
[TBL] [Abstract][Full Text] [Related]
5. Metabolic deregulation in prostate cancer.
Srihari S; Kwong R; Tran K; Simpson R; Tattam P; Smith E
Mol Omics; 2018 Oct; 14(5):320-329. PubMed ID: 30215656
[TBL] [Abstract][Full Text] [Related]
6. NMR-based metabolomics analysis identifies discriminatory metabolic disturbances in tissue and biofluid samples for progressive prostate cancer.
Zheng H; Dong B; Ning J; Shao X; Zhao L; Jiang Q; Ji H; Cai A; Xue W; Gao H
Clin Chim Acta; 2020 Feb; 501():241-251. PubMed ID: 31758937
[TBL] [Abstract][Full Text] [Related]
7. Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation.
Cardoso HJ; Figueira MI; Vaz CV; Carvalho TMA; Brás LA; Madureira PA; Oliveira PJ; Sardão VA; Socorro S
Cell Oncol (Dordr); 2021 Apr; 44(2):385-403. PubMed ID: 33464483
[TBL] [Abstract][Full Text] [Related]
8. The metabolic landscape of urological cancers: New therapeutic perspectives.
Miranda-Gonçalves V; Lameirinhas A; Henrique R; Baltazar F; Jerónimo C
Cancer Lett; 2020 May; 477():76-87. PubMed ID: 32142920
[TBL] [Abstract][Full Text] [Related]
9. Metabolic targets for potential prostate cancer therapeutics.
Twum-Ampofo J; Fu DX; Passaniti A; Hussain A; Siddiqui MM
Curr Opin Oncol; 2016 May; 28(3):241-7. PubMed ID: 26907571
[TBL] [Abstract][Full Text] [Related]
10. Androgen action in the prostate gland.
Yadav N; Heemers HV
Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
[TBL] [Abstract][Full Text] [Related]
11. Decreased glucose bioavailability and elevated aspartate metabolism in prostate cancer cells undergoing epithelial-mesenchymal transition.
Chen Y; Wang K; Liu T; Chen J; Lv W; Yang W; Xu S; Wang X; Li L
J Cell Physiol; 2020 Jul; 235(7-8):5602-5612. PubMed ID: 32017073
[TBL] [Abstract][Full Text] [Related]
12. Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells.
Ippolito L; Marini A; Cavallini L; Morandi A; Pietrovito L; Pintus G; Giannoni E; Schrader T; Puhr M; Chiarugi P; Taddei ML
Oncotarget; 2016 Sep; 7(38):61890-61904. PubMed ID: 27542265
[TBL] [Abstract][Full Text] [Related]
13. Clinical, Cellular, and Molecular Evidence of the Additive Antitumor Effects of Biguanides and Statins in Prostate Cancer.
Jiménez-Vacas JM; Herrero-Aguayo V; Montero-Hidalgo AJ; Sáez-Martínez P; Gómez-Gómez E; León-González AJ; Fuentes-Fayos AC; Yubero-Serrano EM; Requena-Tapia MJ; López M; Castaño JP; Gahete MD; Luque RM
J Clin Endocrinol Metab; 2021 Jan; 106(2):e696-e710. PubMed ID: 33247590
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid differentially modulates the cell cycle and metabolism- related genes in tumor and pre-malignant prostate cells.
Tamarindo GH; Góes RM
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Oct; 1865(10):158766. PubMed ID: 32712248
[TBL] [Abstract][Full Text] [Related]
15. AMPK/GSK3β/β-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming.
Zhang P; Song Y; Sun Y; Li X; Chen L; Yang L; Xing Y
FASEB J; 2018 Jul; 32(7):3924-3935. PubMed ID: 29505302
[TBL] [Abstract][Full Text] [Related]
16. Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score.
Markin PA; Brito A; Moskaleva N; Lartsova EV; Shpot YV; Lerner YV; Mikhajlov VY; Potoldykova NV; Enikeev DV; La Frano MR; Appolonova SA
Metabolomics; 2020 Jun; 16(7):74. PubMed ID: 32556743
[TBL] [Abstract][Full Text] [Related]
17. Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics.
Pal S; Sharma A; Mathew SP; Jaganathan BG
Front Immunol; 2022; 13():955476. PubMed ID: 36618350
[TBL] [Abstract][Full Text] [Related]
18. 1,25(OH)
Abu El Maaty MA; Alborzinia H; Khan SJ; Büttner M; Wölfl S
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1618-1630. PubMed ID: 28651973
[TBL] [Abstract][Full Text] [Related]
19. Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer.
Xu H; Chen Y; Gu M; Liu C; Chen Q; Zhan M; Wang Z
Metabolites; 2021 Nov; 11(11):. PubMed ID: 34822423
[TBL] [Abstract][Full Text] [Related]
20. Functional genomic studies reveal the androgen receptor as a master regulator of cellular energy metabolism in prostate cancer.
Gonthier K; Poluri RTK; Audet-Walsh É
J Steroid Biochem Mol Biol; 2019 Jul; 191():105367. PubMed ID: 31051242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
